Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
暂无分享,去创建一个
[1] D. L. Curtis,et al. The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs. , 1978, Arthritis and rheumatism.
[2] H. Holman,et al. Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.
[3] J. Fries,et al. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. , 1982, The Journal of rheumatology.
[4] P. Gertman,et al. The arthritis impact measurement scales. Further investigations of a health status measure. , 1982, Arthritis and rheumatism.
[5] Meenan Rf. The AIMS approach to health status measurement: conceptual background and measurement properties. , 1982 .
[6] D. Lubeck,et al. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. , 1986, Arthritis and rheumatism.
[7] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[8] S. Larsson,et al. Functional improvement and costs of hip and knee arthroplasty in destructive rheumatoid arthritis. , 1991, Scandinavian journal of rheumatology.
[9] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[10] C. Sherbourne,et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .
[11] J J Anderson,et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[12] M. Liang,et al. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. , 1995, Arthritis and rheumatism.
[13] E. McIntosh,et al. The cost of rheumatoid arthritis. , 1996, British journal of rheumatology.
[14] E. Yelin. The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates. , 1996, The Journal of rheumatology. Supplement.
[15] F. Wolfe,et al. The prevalence and meaning of fatigue in rheumatic disease. , 1996, The Journal of rheumatology.
[16] S. Magnusson. Treatment of rheumatoid arthritis--does it affect society's cost for the disease? , 1996, British journal of rheumatology.
[17] N. Dreyer,et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. , 1997, Arthritis and rheumatism.
[18] W M O'Fallon,et al. Direct medical costs unique to people with arthritis. , 1997, The Journal of rheumatology.
[19] D. Lubeck,et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. , 1997, The Journal of rheumatology.
[20] Carol A. Trujillo,et al. The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients. , 1998, Medical care.
[21] J. Jacobs,et al. Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study. , 1998, British journal of rheumatology.
[22] F. Wolfe,et al. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. , 1998, Arthritis and rheumatism.
[23] E. Yelin,et al. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. , 1999, Arthritis and rheumatism.
[24] J. Edmonds,et al. Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. , 1999, Rheumatology.
[25] B. Jönsson,et al. Economic consequences of the progression of rheumatoid arthritis in Sweden. , 1999, Arthritis and rheumatism.
[26] K. Hieke,et al. The costs of rheumatoid arthritis: an international long-term view. , 2000, Seminars in arthritis and rheumatism.
[27] G. Stucki,et al. Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. , 2000, Rheumatology.
[28] H. Paulus,et al. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. , 2000, The Journal of rheumatology.
[29] G L Freeman,et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.
[30] G. Stucki,et al. Responsiveness of the self-assessed rheumatoid arthritis disease activity index to a flare of disease activity. , 2001, Arthritis and rheumatism.
[31] Rheumatoid arthritis and cardiovascular disease may share similar risk factors. , 2001, Rheumatology.
[32] K. Bungay,et al. The Work Limitations Questionnaire , 2001, Medical care.
[33] S. Gabriel,et al. The epidemiology of rheumatoid arthritis. , 2001, Rheumatic diseases clinics of North America.
[34] F. Wolfe,et al. Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis. , 2002, The Journal of rheumatology.
[35] F. Wolfe,et al. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy. , 2002, The Journal of rheumatology.
[36] J. Brazier,et al. The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.
[37] James M Robins,et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study , 2002, The Lancet.
[38] N. Goodson. Coronary artery disease and rheumatoid arthritis , 2002, Current opinion in rheumatology.
[39] Thomas A Burke,et al. The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis. , 2002, Journal of clinical epidemiology.
[40] Peter Lindgren,et al. Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis. , 2002, Arthritis and rheumatism.
[41] Jason Wittenberg,et al. Clarify: Software for Interpreting and Presenting Statistical Results , 2003 .